We studied the effect of dihydroquercetin (20 mg/kg/day intragastrically for 6 weeks) on mean BP and macro- and microrheological blood parameters in hypertensive SHR rats; in vitro effect of dihydroquercetin on the tone in thoracic aorta rings isolated from hypertensive SHR rats were also examined. At the end of the treatment course, the mean BP in the experimental rats decreased by 11%; the left ventricular mass index by 2%, and whole blood viscosity by 7-10% in comparison with control SHR rats; erythrocyte aggregation half-time increased by 15%; plasma viscosity, hematocrit, and erythrocyte deformability did not change. In in vitro experiments, dihydroquercetin (10—8-10—6M) induced relaxation of the isolated thoracic aorta rings in a dose-dependent manner. Hence, the antihypertensive effect of dihydroquercetin results from the decrease in blood viscosity and vasodilation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Britov AN, Aparina TV. The role of “Kapilar” (dihydroquercetin) in correction of hemodynamic and metabolic disturbances in patients with atherosclerosis and hypertension. Regionar. Krovoobr. Mikrotsirk. 2006;5(2):46-53. Russian.
Zherdev VP, Kolyvanov GB, Litvin AA, Sariev AK, Viglinskaya AO, Gekkiev BI, Grigor’ev AM, Gorlov VV. Comparative pharmacokinetics of dihydroquercetin in rats upon peroral administration of parent substance and flamen D liposomal formulation. Eksper. Klin. Farmakol. 2010;73(1):23-25. Russian.
Zhuravlyov DA. Hypertension models. Spontaneously hypertensive rats. Arterial. Gipertenz. 2009;15(6):722-723. Russian.
Kubatiev AA, Yadigarova ZT, Rud’ko IA, Bykov VA, Tyukavkina NA. Effect of diquertin on platelet content of cyclic nucleotides Bull. Exp. Biol. Med. 1999;128(3):890-891.
Plotnikov MB, Tyukavkina NA, Plotnikova TM. Diquertinbased drugs. Tomsk, 2005. Russian.
Prevention, diagnosis, and therapy of arterial hypertension. Kardiovask. Ter. Prof. 2004;3(4 S1):3-19 Russian.
Ajmani R.S. Hypertension and hemorheology. Clin. Hemorheol. Microcirc. 1997;17(6):397-420.
Baskurt OK, Yalcin O, Meiselman HJ. Hemorheology and vascular control mechanisms. Clin. Hemorheol. Microcirc. 2004;30(3-4):169-178.
Bruschi G, Minari M, Bruschi M.E, Tacinelli L, Milani B, Cavatorta A, Borghetti A. Similarities of essential and spontaneous hypertension. Volume and number of blood cells. Hypertension. 1986;8(11):983-989.
Dornas WC, Silva ME. Animal models for the study of arterial hypertension. J. Biosci. 2011;36(4):731-737.
Pechánová O. Contribution of captopril thiol group to the prevention of spontaneous hypertension. Physiol Res. 2007;56(Suppl. 2):S41-S48.
Plotnikov MB, Aliev OI, Maslov MJ, Vasiliev AS, Tjukavkina NA. Correction of the high blood viscosity syndrome by a mixture of Diquertin and Ascorbic Acid in vitro and in vivo. Phytother. Res. 2003;17(3):276-278.
Pozharitskaya ON, Karlina MV, Shikov AN, Kosman VM, Makarova MN, Makarov VG. Determination and pharmacokinetic study of taxifolin in rabbit plasma by high-performance liquid chromatography. Phytomedicine. 2009;16(2-3):244-251.
Shin S, Hou JX, Suh JS, Singh M. Validation and application of a microfluidic ektacytometer (RheoScan-D) in measuring erythrocyte deformability. Clin. Hemorheol. Microcirc. 2007;37(4):319-328.
Sloop G, Holsworth RE Jr, Weidman JJ, St Cyr JA. The role of chronic hyperviscosity in vascular disease. Ther. Adv. Cardiovasc. Dis. 2015;9(1):19-25.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 162, No. 9, pp. 338-341, September, 2016
Rights and permissions
About this article
Cite this article
Plotnikov, M.B., Aliev, O.I., Sidekhmenova, A.V. et al. Modes of Hypotensive Action of Dihydroquercetin in Arterial Hypertension. Bull Exp Biol Med 162, 353–356 (2017). https://doi.org/10.1007/s10517-017-3614-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-017-3614-4